Bunker Kevin D. 4
4 · Zentalis Pharmaceuticals, Inc. · Filed May 31, 2023
Insider Transaction Report
Form 4
Bunker Kevin D.
Chief Operating Officer
Transactions
- Sale
Common Stock
2023-05-26$30.02/sh−80,000$2,401,248→ 15,000 total(indirect: See Footnote)
Holdings
- 865,157
Common Stock
- 350(indirect: As UTMA custodian for sons)
Common Stock
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires July 31, 2023.
- [F2]The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $30.00 to $30.10. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Represents shares nominally held by Sundog Ranch, Inc. on behalf of the Bunker Family Protection Trust, the sole shareholder of Sundog Ranch, Inc. The Reporting Person and his wife are the primary beneficiaries of the Bunker Family Protection Trust and the Reporting Person and his wife are also directors of Sundog Ranch, Inc. The Reporting Person disclaims beneficial ownership of the securities held by Sundog Ranch, Inc. except to the extent of his pecuniary interest therein, if any.